U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508930) titled 'Russian Extreme Hypertriglyceridemia Registry' on Feb. 28.
Brief Summary: The REGGI registry is a prospective, multicenter observational registry in Russia designed to collect data on patients with extreme hypertriglyceridemia (triglyceride levels >=10 mmol/L). The registry aims to describe the clinical, demographic, and molecular-genetic characteristics of patients, as well as current diagnostic approaches and treatment patterns in real-world practice. The collected data may inform future research and support improvements in patient care.
Study Start Date: Nov. 20, 2025
Study Type: OBSERVATIONAL
Condition:
Hypertriglyceridemia...